Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_32f57a53515b98afbb284cb39a2f17f7 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-05 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B59-002 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-04 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-04 |
filingDate |
2013-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ca0dcfc0e6ca1de359c70eb370641b4c |
publicationDate |
2015-10-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2015299166-A1 |
titleOfInvention |
Deuterated alk inhibitors |
abstract |
This invention relates to novel ALK inhibitors of Formula I: n n n n n n n n n n as defined in the specification, and pharmaceutically acceptable salts thereof. This invention also provides compositions comprising a compound of this invention and the use of such compositions in methods of treating diseases and conditions that are beneficially treated by administering ALK inhibitors. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108350006-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11535630-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11401244-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3381925-A4 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10717753-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018071526-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108948082-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018053222-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-RE49594-E http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2018536667-A |
priorityDate |
2012-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |